ACCREDITATION STATEMENT
The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
CREDIT DESIGNATION STATEMENT
AACR has designated this educational activity for a maximum of 26.75
AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE, AND LEARNING OBJECTIVES
Cancer prevention research and practices are continually evolving. It is critical that the most up-to-date research reaches the bedside, and this is accomplished through the education of the physicians who have daily interactions with patients. Some general recommendations may be made to patients as they pertain to nutrition, physical activity, and age, but more detailed knowledge is needed for physicians to accurately assess patient risk and determine appropriate early detection screening or prophylactic treatment options. This conference will bring together experts from all areas of prevention research to address topics such as the latest advancements in predicting cancer risk, early detection methods, and preventing cancer related to chronic infections.
This trans-disciplinary, international conference is presented for basic, translational, clinical, epidemiological, and behavioral scientists, and physician-scientists involved in cancer prevention research and all subdisciplines of biomedical science related to cancer prevention research. The education disseminated during this conference may be taken back to offices and clinics and immediately applied to daily practice. After participating in this CME activity, physicians should be able to:
- Articulate the global trends of cancer incidence and screening practices.
- Evaluate the key factors that contribute to cancer risk (such as age, heredity, racial/ethnic disparities, and nutrition) and how personalized risk assessments may be made and treatment/prevention plans developed.
- Utilize new technologies (for example, genomics) for early detection of neoplasia and monitoring treatment effects.
- Formulate treatment plans with vaccines and antibiotics for the prophylaxis and treatment of infection (e.g., bacteria, virus)-related neoplasia and for prevention of infection-associated human cancers.
- Critically assess the results of clinical trials of preventive drugs to better explain the risk-benefit issues and challenges encountered in their use.
DISCLOSURE STATEMENT
It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available in the
Program/Proceedings of this conference.
CLAIMING CME CREDIT
Physicians and other health professionals seeking
AMA PRA Category 1 Credits™ for this continuing medical educational activity must complete a
CME Request for Credit Form.
QUESTIONS ABOUT CME?
Please contact the Office of CME at (215) 440-9300 or
cme@aacr.org.